ATLANTA, Aug. 31, 2017 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ:ALIM) (Alimera), a leader in the commercialization and
development of prescription ophthalmic pharmaceuticals, today announced that Rick Eiswirth, President and Chief Financial Officer,
will present at the 19th Annual Rodman & Renshaw Global Investment Conference to be held September 10-12, 2017 at the
Lotte New York Palace Hotel, New York, New York. Alimera Sciences’ presentation will take place Tuesday, September 12th,
2017 at 3:00pm Eastern Time.
A live broadcast of the conference presentation will be available. To access the broadcast, go to the "Investor Relations"
section of the Company's website at www.alimerasciences.com. A replay of the conference presentation will also be available.
About Alimera Sciences, Inc.
www.alimerasciences.com
Alimera, founded in June 2003, is a pharmaceutical company that specializes in the commercialization and development of
prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because
these diseases are not well treated with current therapies and will affect millions of people in our aging populations. Alimera’s
commitment to retina specialists and their patients is manifest in Alimera’s product and development portfolio designed to treat
early-and late-stage diseases. For more information, please visit www.alimerasciences.com.
For press inquiries: Katie Brazel for Alimera Sciences 404-317-8361 kbrazel@bellsouth.net For investor inquiries: CG Capital for Alimera Sciences 877-889-1972 investorrelations@cg.capital
